Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Players, 2022 Update Summary Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) pipeline Target constitutes close to 19 molecules. Out of which approximately ... Read More
-
Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape. Hepatitis A is inflammation of the liver caused by hepatitis A virus. Symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of ... Read More
-
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028
... Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately ... Read More
-
Global Bioanalytical Testing Services, 2021–2027
... contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug development activities. Bioanalytical testing is one of the core aspects of drug development. The testing ... Read More
-
FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032
... expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the ... Read More
-
Bioinformatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bioinformatics Platforms, Knowledge Management Tools, and Bio Informative Services), Application (Genomics, Proteomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others)
... (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others) The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is expected ... Read More
-
Global Animal Biotechnology Market Size study, segmented by Product Type (Vaccine, Drugs, Diagnostic Type, Reproductive And Genetic Product, Feed additives) by Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug development, others) Animal Type (Companion, Livestock) by End-Use (Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics)and Regional Forecasts 2022-2028
... development, others) Animal Type (Companion, Livestock) by End-Use (Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics)and Regional Forecasts 2022-2028 Global Animal Biotechnology Market is valued approximately USD 22.66 billion in 2021 and is anticipated to ... Read More
-
Digital Pathology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Scanners, Software, Storage, and Communication Systems), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery, Disease Diagnostics, Teleconsultation, and Training & Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics)
... Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics) The digital pathology market is expected to grow from US$ 952.62 million in 2022 to US$ 1,892.40 million by 2028; it is expected to ... Read More
-
Biotechnology in Florida - Industry Market Research Report
... same period. Industry establishments increased an annualized 4.5% to 106 locations. Industry employment has decreased an annualized -10.7% to 3,025 workers, while industry wages have decreased an annualized -1.1% to $239.1 million. Companies in this ... Read More
-
Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Forecasts to 2028 – Global Analysis By Component (Cloning Vector, Expression System), Application (Food & Beverages, Agriculture, Therapeutics) and By Geography
... Acid (rDNA) Technology Market is accounted for $171.21 billion in 2022 and is expected to reach $301.67 billion by 2028 growing at a CAGR of 9.9% during the forecast period. Recombinant DNA technology is a ... Read More
-
Contract Pharmaceutical Manufacturing Market, by Service Type (Contract Manufacturing Organization (CMO) (API Manufacturing, Final Dosage Form Manufacturing, and Packaging), Contract Research Organization (CRO) (Drug Discovery, Preclinical Studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, ... Read More
-
Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Epidermolysis Bullosa (Dermatology) pipeline landscape. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin, deformity ... Read More
-
Vitiligo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Vitiligo (Dermatology) pipeline landscape. Vitiligo is a condition in which skin loses melanin, the pigment that determines the color of skin, hair and eyes. Symptoms include premature whitening or graying of the ... Read More
-
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Clostridioides difficile Infections (Infectious Disease) pipeline landscape. Clostridium difficile infections are caused by Clostridium difficile, often called C. difficile or C. diff, a bacterium ... Read More
-
Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... report 'Lysophosphatidic Acid Receptor 1 - Drugs In Development, 2022'; Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are ... Read More
-
Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Type 1 or HCRTR1) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The latest report Orexin Receptor Type 1 - Drugs In Development, 2022, outlays comprehensive ... Read More
-
Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... recently published report 'Adrenocorticotropic Hormone Receptor - Drugs In Development, 2022'; Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) pipeline Target constitutes close to 5 molecules. Out of which approximately ... Read More
-
Angina (Angina Pectoris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape. Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is relieved by ... Read More
-
Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Acinetobacter Infections (Infectious Disease) pipeline landscape. Acinetobacter is a gram-negative coccobacillus. Acinetobacter infections are uncommon but, when they occur, usually involve organ systems that have a high fluid content (respiratory ... Read More
-
Japanese Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Japanese Encephalitis (Infectious Disease) pipeline landscape. Japanese encephalitis is a viral disease that infects animals and humans. It is caused by a flavivirus that affects the membranes around the brain. ... Read More
-
Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Protein Coupled Receptor 119 or GPR119) pipeline Target constitutes close to 8 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucose Dependent Insulinotropic Receptor ... Read More
-
Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... to the recently published report 'Growth Hormone Secretagogue Receptor Type 1 - Drugs In Development, 2022'; Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) pipeline Target constitutes close ... Read More
-
Adenosine Receptor A3 (ADORA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Adenosine Receptor A3 - Drugs In Development, 2022, outlays comprehensive information on the Adenosine Receptor A3 (ADORA3) targeted ... Read More
-
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Receptor 1 or MSHR or MC1R) - Melanocyte-stimulating hormone receptor (MSHR) also known as melanocortin 1 receptor (MC1R), is a G protein-coupled receptor that binds to a peptide hormones known as the melanocortins, which include ... Read More
-
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape. Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage ... Read More
Research Assistance
